Palmitoylethanolamide (PEA) – A Pure and micronized product with a high bioavailability

The positive effect on chronic pain and inflammation has been demonstrated in numerous double blind, placebo-controlled clinical studies. Since many years PEA has being introduced in different formulations with a dosage of 300 mg to 600 mg as nutraceutical.  

The efficacy and safety of Palmitoylethanolamide (PEA) were proven in many trials and the mechanism of action was described in several publications. 

Are you looking for an alternative painkiller? PEA is a right ingredient for your product. 

IMPAG can offer you Palmitoylethanolamide (PEA) in high quality which is produced in an FDA approved facility and supported by full documentation.